(Q52075910)

21 April 2018

title

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. (English)

1 reference

21 April 2018

1 reference

Catalona WJ

1

1 reference

21 April 2018

Southwick PC

2

1 reference

21 April 2018

Slawin KM

3

1 reference

21 April 2018

Partin AW

4

1 reference

21 April 2018

Brawer MK

5

1 reference

21 April 2018

Flanigan RC

6

1 reference

21 April 2018

Patel A

7

1 reference

21 April 2018

Richie JP

8

1 reference

21 April 2018

Walsh PC

9

1 reference

21 April 2018

Scardino PT

10

1 reference

21 April 2018

Lange PH

11

1 reference

21 April 2018

Gasior GH

12

1 reference

21 April 2018

Loveland KG

13

1 reference

21 April 2018

Bray KR

14

1 reference

21 April 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

21 April 2018

published in

Urology

1 reference

21 April 2018

volume

56

1 reference

21 April 2018

issue

2

1 reference

21 April 2018

page(s)

255-260

1 reference

21 April 2018

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Rate of Change in Serum Prostate Specific Antigen Levels as a Method For Prostate Cancer Detection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

The use of percent free prostate specific antigen for staging clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Two-year stability of free and total PSA in frozen serum samples

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific ant

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900637-3

7 January 2021

10.1016/S0090-4295(00)00637-3

Identifiers

DOI

1 reference

21 April 2018

release_6v7ixlhdpjh4lazsue5yfxtale

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6v7ixlhdpjh4lazsue5yfxtale

24 November 2022

mapped directly with Wikidata item

1 reference

21 April 2018